Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,192,817 papers from all fields of science
Search
Sign In
Create Free Account
5-fluorouridine 5'-triphosphate
Known as:
FUTP
, uridine 5'-(tetrahydrogen triphosphate), 5-fluoro-
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Uridine Triphosphate
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Locoregional administration of 5-fluoro-2′-deoxyuridine (FdUrd) in Novikoff hepatoma in the rat: effects of dose and infusion time on tumor growth and on FdUrd metabolite levels in tumor tissue as…
B. Naser-Hijazi
,
M. Berger
,
D. Schmähl
,
P. Schlag
,
W. Hull
Journal of Cancer Research and Clinical Oncology
2005
Corpus ID: 44246680
SummaryThe influence of infusion time and dose on the anticancer efficacy of 5-fluoro-2′-deoxyuridine (FdUrd) was investigated…
Expand
2000
2000
Monitoring of the intracellular activation of 5‐fluorouracil to deoxyribonucleotides in HT29 human colon cell line: application to modulation of metabolism and cytotoxicity study
J. Ciccolini
,
Laurent Peillard
,
C. Aubert
,
P. Formento
,
G. Milano
,
Jacques Catalin
Fundamental & Clinical Pharmacology
2000
Corpus ID: 37117573
Abstract— An HPLC method was developed for in vitro detection and monitoring of intracellular metabolites of [3H]‐5‐fluorouracil…
Expand
1998
1998
Mechanisms for 5-fluorouracil resistance in human colon cancer DLD-1 cells.
M. Inaba
,
Y. Naoe
,
J. Mitsuhashi
Biological and Pharmaceutical Bulletin
1998
Corpus ID: 19349374
A 5-fluorouracil (5-FU)-resistant subline, DLD-1/5-FU, was established by repeated 5-d exposures of human colon cancer DLD-1…
Expand
1997
1997
Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells.
Q. Ren
,
C. V. Groeningen
,
+5 authors
J. Grem
Oncology Research
1997
Corpus ID: 25553784
To explore the determinants of cytotoxicity during prolonged exposure to pharmacologically relevant concentrations of 5…
Expand
Highly Cited
1996
Highly Cited
1996
Reduced Activity of Anabolizing Enzymes in 5‐Fluorouracil‐resistant Human Stomach Cancer Cells
M. Inaba
,
J. Mitsuhashi
,
+6 authors
M. Fukushima
Japanese journal of cancer research : Gann
1996
Corpus ID: 1785047
The mechanism of resistance to 5‐fluorouracil (5‐FU) was studied with NUGC‐3/5FU/L, a human stomach cancer cell line which had…
Expand
1996
1996
The cellular interaction of 5-fluorouracil and cisplatin in a human colon carcinoma cell line.
P. Johnston
,
F. Geoffrey
,
J. Drake
,
D. Voeller
,
J. Grem
,
C. Allegra
European Journal of Cancer
1996
Corpus ID: 9066896
1984
1984
Substrate properties of 5-fluorouridine diphospho sugars detected in hepatoma cells.
G. Weckbecker
,
D. Keppler
Biochemical Pharmacology
1984
Corpus ID: 26574544
Highly Cited
1981
Highly Cited
1981
Selective activation of 5'-deoxy-5-fluorouridine by tumor cells as a basis for an improved therapeutic index.
R. Armstrong
,
R. Diasio
Cancer Research
1981
Corpus ID: 25768583
The intracellular metabolism of a new fluoropyrimidine, 5'-deoxy-5-fluorouridine (5'-dFUrd), was compared with the metabolism of…
Expand
Highly Cited
1980
Highly Cited
1980
Metabolism and biological activity of 5'-deoxy-5-fluorouridine, a novel fluoropyrimidine.
R. Armstrong
,
R. Diasio
Cancer Research
1980
Corpus ID: 37634214
5'-Deoxy-5-fluorouridine (5'-dFUrd; Roche 21-9738) is a recently synthesized antineoplastic agent with therapeutic potential. The…
Expand
1980
1980
The effect of 5-fluorouridine 5'-triphosphate on RNA transcribed in isolated nuclei in vitro.
R. Glazer
,
M. Legraverend
Molecular Pharmacology
1980
Corpus ID: 42570536
Using nuclei prepared from rat liver, the effect of 5-fluorouridine 59-triphosphate (FUTP) was assessed on the nearest neighbor…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE